Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas

Title: Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas
Authors: Hübschmann, Daniel; Kleinheinz, Kortine; Wagener, Rabea; Bernhart, Stephan H.; López, Cristina; Toprak, Umut H.; Sungalee, Stephanie; Ishaque, Naveed; Kretzmer, Helene; Kreuz, Markus; Waszak, Sebastian M.; Paramasivam, Nagarajan; Ammerpohl, Ole; Aukema, Sietse M.; Beekman, Renée; Bergmann, Anke K.; Bieg, Matthias; Binder, Hans; Borkhardt, Arndt; Borst, Christoph; Brors, Benedikt; Bruns, Philipp; Carrillo de Santa Pau, Enrique; Claviez, Alexander; Doose, Gero; Haake, Andrea; Karsch, Dennis; Haas, Siegfried; Hansmann, Martin-Leo; Hoell, Jessica I.; Hovestadt, Volker; Huang, Bingding; Hummel, Michael; Jäger-Schmidt, Christina; Kerssemakers, Jules N. A.; Korbel, Jan O.; Kube, Dieter; Lawerenz, Chris; Lenze, Dido; Martens, Joost H. A.; Ott, German; Radlwimmer, Bernhard; Reisinger, Eva; Richter, Julia; Rico, Daniel; Rosenstiel, Philip; Rosenwald, Andreas; Schillhabel, Markus; Stilgenbauer, Stephan; Stadler, Peter F.; Martín-Subero, José I.; Szczepanowski, Monika; Warsow, Gregor; Weniger, Marc A.; Zapatka, Marc; Valencia, Alfonso; Stunnenberg, Hendrik G.; Lichter, Peter; Möller, Peter; Loeffler, Markus; Eils, Roland; Klapper, Wolfram; Hoffmann, Steve; Trümper, Lorenz; Küppers, Ralf; Schlesner, Matthias; Siebert, Reiner; Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany; Department for Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg, Heidelberg, Germany; University of Duesseldorf, Medical Faculty, Department of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Düsseldorf, Germany; Transcriptome Bioinformatics, LIFE Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany; Intitute of Human Genetics, Christian-Albrechts-University, Kiel, Germany; Bioinformatics and Omics Data Analytics (B240), German Cancer Research Center (DKFZ), Heidelberg, Germany; EMBL Heidelberg, Genome Biology, Heidelberg, Germany; DKFZ-HIPO, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany; Institute for Medical Informatics Statistics and Epidemiology, Leipzig, Germany; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany; Hematopathology Section, Christian-Albrechts-University, Kiel, Germany; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; Bioinformatics Group, Department of Computer, University of Leipzig, Leipzig, Germany; Department of Internal Medicine/Hematology, Friedrich-Ebert-Hospital, Neumünster, Neumünster, Germany; Division of Applied Bioinformatics (G200), German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Theoretical Bioinformatics (B080), German Cancer Research Center (DKFZ), Heidelberg, Germany; Computational Biology Group, Precision Nutrition and Cancer Research Program, IMDEA Food Institute, Madrid, Spain; Department for Internal Medicine II, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; Senckenberg Institute of Pathology, University of Frankfurt Medical School, Frankfurt am Main, Germany; Division of Molecular Genetics, German Cancer Consortium (DKFK), German Cancer Research Center (DKFZ), Heidelberg, Germany; College of Big Data and Internet, Shenzhen Technology University, Shenzhen, China; Institute of Pathology, Charité – University Medicine Berlin, Berlin, Germany; Department of Hematology and Oncology, Georg-Augusts-University of Göttingen, Göttingen, Germany; Department of Molecular Biology, Radboud University, Faculty of Science, Nijmegen, The Netherlands; Department of Clinical Pathology, Robert-Bosch-Hospital and Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology, Stuttgart, Germany; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK; Institute of Clinical Molecular Biology, Christian-Albrechts-University, Kiel, Germany; Institute of Pathology, University of Wuerzburg and Comprehensive Cancer Center Mainfranken, Wuerzburg, Germany; Department for Internal Medicine III, Ulm University, Ulm, Germany; German Cancer Consortium (DKTK), Essen, Germany; ICREA, Barcelona, Spain; Institute of Pathology, Medical Faculty of the Ulm University, Ulm, Germany; Institute for Informatics, Faculty of Computer Science and Medical Faculty, University of Augsburg, Augsburg, Germany
Contributors: Hübschmann, Daniel; Kleinheinz, Kortine; Wagener, Rabea; Bernhart, Stephan H.; López, Cristina; Toprak, Umut H.; Sungalee, Stephanie; Ishaque, Naveed; Kretzmer, Helene; Kreuz, Markus; Waszak, Sebastian M.; Paramasivam, Nagarajan; Ammerpohl, Ole; Aukema, Sietse M.; Beekman, Renée; Bergmann, Anke K.; Bieg, Matthias; Binder, Hans; Borkhardt, Arndt; Borst, Christoph; Brors, Benedikt; Bruns, Philipp; Carrillo de Santa Pau, Enrique; Claviez, Alexander; Doose, Gero; Haake, Andrea; Karsch, Dennis; Haas, Siegfried; Hansmann, Martin-Leo; Hoell, Jessica I.; Hovestadt, Volker; Huang, Bingding; Hummel, Michael; Jäger-Schmidt, Christina; Kerssemakers, Jules N. A.; Korbel, Jan O.; Kube, Dieter; Lawerenz, Chris; Lenze, Dido; Martens, Joost H. A.; Ott, German; Radlwimmer, Bernhard; Reisinger, Eva; Richter, Julia; Rico, Daniel; Rosenstiel, Philip; Rosenwald, Andreas; Schillhabel, Markus; Stilgenbauer, Stephan; Stadler, Peter F.; Martín-Subero, José I.; Szczepanowski, Monika; Warsow, Gregor; Weniger, Marc A.; Zapatka, Marc; Valencia, Alfonso; Stunnenberg, Hendrik G.; Lichter, Peter; Möller, Peter; Loeffler, Markus; Eils, Roland; Klapper, Wolfram; Hoffmann, Steve; Trümper, Lorenz; Küppers, Ralf; Schlesner, Matthias; Siebert, Reiner; Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany; Department for Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg, Heidelberg, Germany; University of Duesseldorf, Medical Faculty, Department of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Düsseldorf, Germany; Transcriptome Bioinformatics, LIFE Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany; Intitute of Human Genetics, Christian-Albrechts-University, Kiel, Germany; Bioinformatics and Omics Data Analytics (B240), German Cancer Research Center (DKFZ), Heidelberg, Germany; EMBL Heidelberg, Genome Biology, Heidelberg, Germany; DKFZ-HIPO, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany; Institute for Medical Informatics Statistics and Epidemiology, Leipzig, Germany; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany; Hematopathology Section, Christian-Albrechts-University, Kiel, Germany; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; Bioinformatics Group, Department of Computer, University of Leipzig, Leipzig, Germany; Department of Internal Medicine/Hematology, Friedrich-Ebert-Hospital, Neumünster, Neumünster, Germany; Division of Applied Bioinformatics (G200), German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Theoretical Bioinformatics (B080), German Cancer Research Center (DKFZ), Heidelberg, Germany; Computational Biology Group, Precision Nutrition and Cancer Research Program, IMDEA Food Institute, Madrid, Spain; Department for Internal Medicine II, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; Senckenberg Institute of Pathology, University of Frankfurt Medical School, Frankfurt am Main, Germany; Division of Molecular Genetics, German Cancer Consortium (DKFK), German Cancer Research Center (DKFZ), Heidelberg, Germany; College of Big Data and Internet, Shenzhen Technology University, Shenzhen, China; Institute of Pathology, Charité – University Medicine Berlin, Berlin, Germany
Publication Year: 2021
Collection: Georg-August-Universität Göttingen: GoeScholar
Description: B cells have the unique property to somatically alter their immunoglobulin (IG) genes by V(D)J recombination, somatic hypermutation (SHM) and class-switch recombination (CSR). Aberrant targeting of these mechanisms is implicated in lymphomagenesis, but the mutational processes are poorly understood. By performing whole genome and transcriptome sequencing of 181 germinal center derived B-cell lymphomas (gcBCL) we identified distinct mutational signatures linked to SHM and CSR. We show that not only SHM, but presumably also CSR causes off-target mutations in non-IG genes. Kataegis clusters with high mutational density mainly affected early replicating regions and were enriched for SHM- and CSR-mediated off-target mutations. Moreover, they often co-occurred in loci physically interacting in the nucleus, suggesting that mutation hotspots promote increased mutation targeting of spatially co-localized loci (termed hypermutation by proxy). Only around 1% of somatic small variants were in protein coding sequences, but in about half of the driver genes, a contribution of B-cell specific mutational processes to their mutations was found. The B-cell-specific mutational processes contribute to both lymphoma initiation and intratumoral heterogeneity. Overall, we demonstrate that mutational processes involved in the development of gcBCL are more complex than previously appreciated, and that B cell-specific mutational processes contribute via diverse mechanisms to lymphomagenesis. ; Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) https://doi.org/10.13039/501100002347
Document Type: article in journal/newspaper
Language: English
DOI: 10.1038/s41375-021-01251-z
Availability: https://resolver.sub.uni-goettingen.de/purl?gro-2/123416; https://doi.org/10.1038/s41375-021-01251-z
Rights: info:eu-repo/semantics/openAccess ; CC BY 4.0 ; https://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.CBD616A3
Database: BASE